logo
#

Latest news with #RekhaJhunjhunwala

Jhunjhunwala family-backed IKS Health sees Rs 500 crore block deal; stock slides 4%
Jhunjhunwala family-backed IKS Health sees Rs 500 crore block deal; stock slides 4%

Economic Times

time19-06-2025

  • Business
  • Economic Times

Jhunjhunwala family-backed IKS Health sees Rs 500 crore block deal; stock slides 4%

Live Events (You can now subscribe to our (You can now subscribe to our ETMarkets WhatsApp channel Around 30 lakh shares of IKS Health , the tech-driven healthcare services firm backed by the Jhunjhunwala family , changed hands in a block deal worth Rs 499 crore on Thursday, representing 1.75% of the company's equity. The stock slipped as much as 3.7% intraday to Rs 1,640.55 on the BSE following the shares were traded at an average price of Rs 1,659, with the floor price set at Rs 1,650—a 2.6% discount to Wednesday's closing price of Rs 1,695, CNBC-TV18 reported. The identities of the buyers and sellers were not officially disclosed, though sources told CNBC-TV18 that multiple individual investors were likely on the sell block deal came just a day after the end of IKS Health's six-month post-IPO lock-in period on Wednesday. With the lock-in lifted, 10.5 crore shares—worth nearly $20 billion—became eligible for trade. Market participants had been anticipating such a stock has now fallen over 12% in two sessions and is trading about 22% below its post-listing high of Rs 2, Health is backed by the Jhunjhunwala family through three discretionary trusts—Nistha, Aryavir, and Aryaman—each holding a 16.37% stake in the company as of March 2025. Rekha Jhunjhunwala also holds a 0.23% stake but did not participate in the IPO the company listed on December 19, 2024, the Jhunjhunwala family reportedly made a staggering 530x return on their investment. The Rs 2,500 crore IPO was oversubscribed 53 times and debuted at Rs 1,900 on the NSE, a 43% premium over the issue price of Rs 1, part of the offer-for-sale, the three family trusts offloaded 33.57 lakh shares out of the 8.94 crore they held as of the September quarter. The IPO did not involve any fresh capital Health, formally known as Inventurus Knowledge Solutions, provides a care enablement platform for physician enterprises across the US, Canada, and Australia, with a primary focus on the US market. It serves more than 778 healthcare organizations, including high-profile clients such as Mass General Brigham Inc. , Texas Health Care PLLC, and The GI Alliance company has posted strong financial growth in recent years, with revenue, EBITDA, and profit rising at a CAGR of 54.3%, 32.3%, and 26.1%, respectively, between FY22 and FY24. For the six months ended September 2024, revenue from operations doubled to Rs 1,283 crore, while net profit rose marginally to Rs 208 the lock-in period now over and the first wave of selling underway, market watchers are keenly observing whether more exits by early investors or promoters will follow in the coming weeks.

Top stocks to watch today, June 16: NTPC, Godrej Properties, ONGC, Oil India, SpiceJet, Natco Pharma and more
Top stocks to watch today, June 16: NTPC, Godrej Properties, ONGC, Oil India, SpiceJet, Natco Pharma and more

Business Upturn

time16-06-2025

  • Business
  • Business Upturn

Top stocks to watch today, June 16: NTPC, Godrej Properties, ONGC, Oil India, SpiceJet, Natco Pharma and more

Indian stock markets are likely to open on a cautious note on Monday, June 16, as global investors monitor geopolitical tensions in the Middle East. Here's a look at key stocks that will be in focus today: ONGC, Oil India, Paint Companies, OMCs Crude oil prices remain elevated with Brent trading near $75 per barrel due to the ongoing Iran-Israel conflict. This could impact oil-linked sectors including oil exploration companies, paint manufacturers, and oil marketing companies (OMCs). Vedanta Ltd The company's board will meet on June 18 to consider the first interim dividend for FY26. Investors will watch for the dividend quantum and commentary on future payouts. NTPC NTPC has commenced operations at one 660 MW phase of its three-phase super thermal power project. The operationalisation adds to the company's thermal generation capacity. Godrej Properties Godrej Properties will develop a 14-acre residential project in Hoskote, East Bengaluru. The project has an estimated revenue potential of ₹1,500 crore. Syngene International The US Food and Drug Administration (US FDA) has issued a 'No Action Indicated' (NAI) classification for Syngene's Semicon Park facility in Bengaluru, indicating compliance with regulatory norms. HBL Power Systems HBL Engineering has received a Letter of Acceptance (LoA) worth ₹164 crore for Kavach-related work in the Vijayawada–Ballarshah section of South Central Railway. Zee Entertainment Zee Entertainment's board is scheduled to meet today to discuss potential fundraising plans and a long-term growth roadmap over the next three to five years. Tanla Platforms The company's board will meet today to consider a share buyback proposal, which may impact stock movement based on the buyback size and premium. Birla Corporation Birla Corp has been declared the preferred bidder for a limestone block spanning 500 hectares in Rajasthan. This could aid raw material security for its cement business. SpiceJet The airline reported a net profit in FY25, marking its first annual profit in seven years. EBITDA rose 19% year-on-year. The financial performance may lift investor sentiment. Sun Pharmaceutical Sun Pharma has received eight observations from the US FDA for its Halol facility, following an inspection. Regulatory compliance remains a key monitorable. Nazara Technologies Investor Rekha Jhunjhunwala has exited Nazara Tech by selling 27.23 lakh shares via block deals on Friday. Stock may react to the large stake sale. Natco Pharma The US FDA issued one observation for Natco's API manufacturing facility in Hyderabad following an inspection. Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information. Ahmedabad Plane Crash

Nazara Tech in focus as Rekha Jhunjhunwala sells entire stake amid stock surge
Nazara Tech in focus as Rekha Jhunjhunwala sells entire stake amid stock surge

Time of India

time16-06-2025

  • Business
  • Time of India

Nazara Tech in focus as Rekha Jhunjhunwala sells entire stake amid stock surge

Synopsis Nazara Technologies' share price will be in focus as Rekha Jhunjhunwala exits the company, selling her remaining 3% stake worth ₹334 crore via bulk deals on June 13. Her exit comes as the stock nears a four-year high. Earlier, between June 2 and June 6, she had sold 17.38 lakh shares for an estimated Rs 218 crore. Overall, her holding has come down from over 10% in June 2022 to nil.

Stocks in news: Adani Enterprises, Sun Pharma, Vedanta, Nazara Tech, NTPC
Stocks in news: Adani Enterprises, Sun Pharma, Vedanta, Nazara Tech, NTPC

Time of India

time16-06-2025

  • Business
  • Time of India

Stocks in news: Adani Enterprises, Sun Pharma, Vedanta, Nazara Tech, NTPC

Markets remained under pressure and declined by over a percent in the week gone by, weighed down by rising geopolitical tensions and mixed global cues. In today's trade, shares of Adani Enterprises , Sun Pharma , Vedanta , Nazara Tech, NTPC among others will be in focus due to various news developments. Adani Enterprises Indian conglomerate Adani group's Chief Financial Officer Jugeshinder Robbie Singh on Sunday said reports of company's Haifa port in Israel being harmed by the Iranian ballistic missile attack are false. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like "기관지 호흡기질환" 특효인 [국내1%] 마신즉시 녹아 2주만에 "가슴통증" 벗어났다! 목구멍 가래·기관지 복구법 Undo Bajaj Finance Shares of Bajaj Finance will trade ex-bonus and ex-stock split starting June 17. The company had announced a 4:1 bonus issue and a stock split of Rs 2 face value shares into two shares of Rs 1 each alongside its Q4 results. Sun Pharma Sun Pharmaceutical confirmed that the US FDA concluded an inspection of its Halol facility with eight observations in a Form 483. Vedanta Vedanta said it will hold a board meeting on June 18 to consider its first interim dividend proposal for FY26. The record date has been set for June 24. Live Events Nazara Technologies Investor Rekha Jhunjhunwala sold over 27 lakh shares of Nazara Technologies on June 13, reducing her stake in the gaming firm. Syngene International Syngene International received an EIR from the US FDA for its GMP manufacturing facilities in Biocon Park. NTPC State-run power producer NTPC has started commercial operations of Unit-3 (660 MW) at its North Karanpura Super Thermal Power Project. ITC ITC announced the completion of its acquisition of 100% stake in Sresta Natural Bioproducts (SNBPL) for Rs 400 crore. SNBPL and its overseas arms in the US and UAE now become wholly owned subsidiaries of ITC. Birla Corporation Birla Corporation has emerged as the preferred bidder for the Gourum Khan Ki Dhani (South) limestone block in Rajasthan.

Rekha Jhunjhunwala Sells Entire 5.07% Stake In This Gaming Firm, Stock At 52-Week High
Rekha Jhunjhunwala Sells Entire 5.07% Stake In This Gaming Firm, Stock At 52-Week High

News18

time14-06-2025

  • Business
  • News18

Rekha Jhunjhunwala Sells Entire 5.07% Stake In This Gaming Firm, Stock At 52-Week High

'From 9th June 2025 to 12th June 2025 they had sold shares totaling to 17,21,500 (i.e 1.9648%) and on 13 June 2025 they sold 27,23,620 shares thereby resulting in a total change of 5,0734% since the last disclosure made," Nazara Technologies Ltd said in the filing. Shares of Nazara Technologies Ltd jumped 6.49 per cent on BSE on Friday to end at Rs 1327.85 apiece. Earlier, the scrip opened at Rs 1234.20 apiece, against the previous day close at Rs 1246.90 apiece. It also touched its 52-week high of Rs 1340 apiece. In the horizon of 1 year, shares of Nazara Technologies have given a return of 56 per cent to investors. Rekha Jhunjhunwala has had stakes in Canara Bank, Tata Motors, Wockhardt, Titan Company, Jubilant Pharmova, Geojit Financial Services, Indian Hotels Company, Federal Bank, according to Trendlyne. One of the largest holdings in her portfolio remains Titan Company, valued at Rs 15,670.1 crore, where she holds 45.79 million shares, accounting for a 5.2% stake. Another prominent holding is Tata Motors, with a market value of Rs 3,401.5 crore and a 1.3% stake. She has also increased exposure to the financial space through Canara Bank, holding 132.44 million shares worth Rs 1,476.2 crore, with a 1.5% stake as of March 2025. In the healthcare and pharma segment, Rekha holds 10.24 million shares in Jubilant Pharmova, worth Rs 1,120.9 crore with a 6.4% stake, and a 1.8% stake in Wockhardt, valued at Rs 503.9 crore. Her hotel and hospitality investment in Indian Hotels Company stands at a 2.0% stake, worth Rs 2,118 crore, and she also holds a sizable 7.2% stake in Geojit Financial Services, indicating a balanced mix of traditional and emerging sectors in her portfolio.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store